Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,906
in 7 filings

Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-09-14 RITTER DALE Vice President, Finance Exercise or conversion +12,500 19,827
2017-01-17 RITTER DALE Vice President, Finance Exercise or conversion · Restricted Stock Units −12,500 37,500
2017-01-17 RITTER DALE Vice President, Finance Grant or award · Restricted Stock Units +50,000 50,000
2016-03-22 RITTER DALE Vice President, Finance Grant or award · Stock Options (Right to Buy) +40,000 40,000
2015-06-24 RITTER DALE Vice President, Finance Grant or award · Stock Options (Right to Buy) +25,000 $5.03 $126K 68,982

Page 1 of 1 · 5 trades